'Huge pipeline': Why this beaten-up ASX 200 share could have major growth potential

A fund manager has picked out a beaten-up opportunity for investors.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One fund manager has singled out the S&P/ASX 200 Index (ASX: XJO) share Nufarm Ltd (ASX: NUF) as an investing opportunity.

L1 Capital has given a vote of confidence in the ASX agriculture share, particularly at its current share price.

For investors who aren't familiar with the company, Nufarm describes itself as a global crop protection and seed technology specialist. Nufarm was reportedly the first operation to develop and commercialise planted-based Omega-3 and has also developed and commercialised advanced bioenergy feedstock technology.

As we can see on the chart below, the Nufarm share price is down by around 30% since its 52-week high in December 2022.

a farmer kneels on one leg and closely examines soil from his farm against a blue sky backdrop.

Image source: Getty Images

Why does L1 like the ASX 200 share?

The fund manager explained Nufarm's recent trading was impacted by weaker US rainfall and "transitory farmer de-stocking impacts".

L1 said the "world's leading Omega-3 seed technology" has the potential to deliver a "step change" in Nufarm's earnings in FY25 or FY26. It pointed out the long-term growth aspiration of the company is to grow earnings before interest, tax, depreciation and amortisation (EBITDA) from $59 million in FY22 to $146 million in FY26.

The L1 investment team says there is a huge pipeline of crop protection product launches.

It also likes the valuation the Nufarm share price is trading at, which I'll get to in a moment.

FY23 outlook

Just over a month ago, the ASX 200 share updated its outlook for the 2023 financial year, which was for the 12 months ending 30 September 2023.

In FY23, it expects to report underlying EBITDA in the range of between $430 million to $440 million. Its leverage ratio is expected to be between 2.1 to 2.4 times. Inventory has reduced during the period, though this was "more than offset by an increase in receivables due to the phasing of sales".

Nufarm CEO Greg Hunt said:

We expect to deliver another good result for FY23, following on from the record earnings result delivered in FY22. Despite a very challenging operating environment, we have seen the benefits of revenue diversification across the group, with some softness in crop protection offset by a very strong performance in seed technologies.

We remain on track for our FY26 revenue aspirations.

Nufarm share price valuation

According to L1, the ASX 200 share is trading at roughly 12 times FY24's estimated earnings and on average is delivering earnings per share (EPS) growth of 15% per annum.

In other words, the EPS growth rate is higher than the company's price/earnings (P/E) ratio. When the price-to-earnings-growth (PEG) ratio is less than one, that's seen as an attractive opportunity.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A business woman looks unhappy while she flies a red flag at her laptop.
Share Market News

These are the 10 most shorted ASX shares

Let's see which shares short sellers are targeting this week.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Brambles, CBA, and Macquarie shares

Do analysts rate these shares as buys? Let's find out.

Read more »

A female stockbroker reviews share price performance in her office with the city shown in the background through her windows
Share Market News

5 things to watch on the ASX 200 on Monday

Here's what to expect on the local market at the start of the week.

Read more »

5 mini houses on a pile of coins.
Opinions

2 ASX shares I'd much rather buy than an investment property

Certain ASX shares can offer exposure to real estate with more income potential.

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A businessman wears armour and holds a shield and sword.
Share Market News

Nervous investors turn to ASX 200 defensives as global energy shock drags on

ASX investors sought safety in defensive sectors last week.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »